Andrew Louis Pecora, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

UMDNJ-Robert Wood Johnson Medical School - Piscataway/New Brunswick/Camden NJ
Rank: Associate Professor
Years: 2004-2012

Georgetown University School Of Medicine - Washington DC
Rank: Professor of Medicine and Oncology
Years: 2012-present

None Reported

Autologous stem cell transplantation in multiple myeloma patients over age 75
J Clin Oncol 36
suppl; abstr 8025
Date: 01 2018

Engraftment Syndrome in the Setting of Autologous Stem Cell Transplantation for Multiple Myeloma – a Single Institution Review of over 600 Patients.
BLOOD
134 Supplement 14576
Date: 01 2019

Evomela Significantly Increases the Risk of Engraftment Syndrome in Patients with Multiple Myeloma Treated with Autologous Stem Cell Transplantation
BLOOD
1234 Supplement 11911
Date: 01 2019

Evomela Significantly Increases the Risk of Engraftment Syndrome in Patients with Multiple Myeloma Treated with Autologous Stem Cell Transplantation
BLOOD
134 Supplement 13316
Date: 01 2019

Phase I Study of Single-Agent and Combined Checkpoint Inhibition (CI) after Allogenic Hematopoietic Stem Cell Transplantation (alloHCT) in Patients at High Risk for post-Transplant Recurrence
BLOOD
134 Supplement 15618
Date: 01 2019

Sustained Hematopoietic Recovery after Salvage Autologous Stem Cell Transplants after Long Term Storage of Cryopreserved Hematopoietic Progenitor Stem Cells (HPSC)
BLOOD
134 Supplement 14475
Date: 01 2019

Two Year Update of Phase II Trial of Pembrolizumab, Lenalidomide and Dexamethasone AS Post-Autologous Stem Cell Transplant Consolidation in Patients with High-Risk Multiple Myeloma.
BLOOD
(1234 Supplement 11911).
Date: 01 2019